CardioVis Selected for TNT’s Spring 2026 Accelerator Cohort
CardioVis has been selected for TNT’s Spring 2026 Accelerator Cohort, advancing its clinically focused AI Copilot platform for robotic cardiac surgery through mentorship, founder support, and strategic growth resources.
CardioVis is proud to announce its selection into TNT’s Spring 2026 Accelerator Cohort, a major step toward bringing clinically meaningful AI into the robotic cardiac surgery suite.
Healthcare is defined by the tools we put in the hands of clinicians. TNT’s Spring 2026 Accelerator Cohort is a Boston-based pre-seed accelerator supporting high-impact founders from MIT, Harvard, and beyond. Their zero-equity support, including dedicated mentorship, investor access, and over $200,000 in cloud credits, culminates in a highly anticipated Demo Day at Boston Tech Week in May 2026.
Elevating Surgical Guidance
This milestone supports CardioVis as it advances its AI Copilot platform for robotic cardiac surgery. We are building console-native, robot-integrated software designed for direct operating room deployment.
Our platform analyzes live surgical video and robot telemetry to anticipate high-risk transitions, deliver concise, clinically specific guidance, and generate structured case maps for debrief, documentation, and quality review. By harnessing AI, we can help clinicians improve care without disrupting their existing workflows.
Strategic Growth and Ecosystem Integration
Participation in the TNT cohort will help accelerate CardioVis’s product and company development through close mentorship, founder community integration, and strategic introductions across the Boston innovation ecosystem. The program’s rigorous operational focus includes weekly founder sessions, mentor kickoffs, and exclusive exposure to an audience of over 300 investors, operators, and press representatives.
We are honored to join the Spring 2026 cohort and look forward to building the next generation of clinically meaningful AI for robotic cardiac surgery.